GSK's new 'ethical' customer approach: Is it delivering?
GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term.
Will GSK’s new transparent, reputation-boosting sales model be a template for the entire industry?
Please subscribe to view the analysis report